Cytek Biosciences (CTKB) EBT Margin (2020 - 2026)
Cytek Biosciences (CTKB) reported EBT Margin of 39.36% for Q1 2026, down 1219.0% on a YoY basis from 3.52% in Q1 2025, and down 506.82% quarter-over-quarter from 6.49% in Q4 2025.
Cytek Biosciences (CTKB) EBT Margin (2020 - 2026) Analysis & Trends
Cytek Biosciences has reported EBT Margin for 7 years, with the latest figure at 39.36% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 1219.0% year-over-year to 39.36%; the trailing twelve-month figure through Mar 2026 stood at 17.61% (down 1356.0% YoY), and the FY2025 full-year result was 14.81%, down 1197.0% from the prior year.
- EBT Margin for Q1 2026 stood at 39.36%, down from 6.49% in the prior quarter.
- The five-year high for EBT Margin was 17.96% in Q4 2024, with the low at 39.36% in Q1 2026.
- Historically, EBT Margin has averaged 9.36% across 5 years, with a median of 9.42% in 2022.
- Annual changes were most pronounced in 2024 — EBT Margin surged 1090 bps — and 2025, when it plunged 2445 bps.
- Cytek Biosciences' EBT Margin stood at 8.51% in 2022, then fell by 17 bps to 7.06% in 2023, then soared by 154 bps to 17.96% in 2024, then tumbled by 136 bps to 6.49% in 2025, then slumped by 507 bps to 39.36% in 2026.
- The last three EBT Margin figures came in at 39.36% (Q1 2026), 6.49% (Q4 2025), and 14.86% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.17% |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | -39.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.36% |
| Dec 31, 2025 | -6.49% |
| Sep 30, 2025 | -14.86% |
| Jun 30, 2025 | -14.86% |
| Mar 31, 2025 | -27.18% |
| Dec 31, 2024 | 17.96% |
| Sep 30, 2024 | 0.30% |
| Jun 30, 2024 | -15.41% |
| Mar 31, 2024 | -20.05% |
| Dec 31, 2023 | 7.06% |
| Sep 30, 2023 | -8.72% |
| Jun 30, 2023 | -13.27% |
| Mar 31, 2023 | -24.37% |
| Dec 31, 2022 | 8.51% |
| Sep 30, 2022 | 4.57% |
| Jun 30, 2022 | -3.49% |
| Mar 31, 2022 | -9.42% |
| Dec 31, 2021 | -0.51% |
| Sep 30, 2021 | 6.04% |
| Jun 30, 2021 | 10.74% |